General management strategy for epidermal growth factor receptor inhibitor–associated papulopustular eruption

Saved in:
Bibliographic Details
Published in:Journal of the American Academy of Dermatology 2016-11, Vol.75 (5), p.e191-e191
Main Authors: Farahnik, Benjamin, BA, Kwong, Bernice, MD, Murase, Jenny, MD
Format: Article
Language:English
Subjects:
Adrenal Cortex Hormones - therapeutic use
Anti-Infective Agents, Local - therapeutic use
Antibiotic Prophylaxis
Antineoplastic Agents - adverse effects
Antineoplastic Agents - therapeutic use
chemotherapy side effect
Dermatology
Drug Eruptions - drug therapy
Drug Eruptions - etiology
Drug Eruptions - prevention & control
Emollients - therapeutic use
epidermal growth factor receptor inhibitor
Erythema - chemically induced
Humans
management
Neoplasm Proteins - antagonists & inhibitors
papulopustular eruption
Protein Kinase Inhibitors - adverse effects
Protein Kinase Inhibitors - therapeutic use
Pruritus - chemically induced
Receptor, Epidermal Growth Factor - antagonists & inhibitors
Skin Diseases, Bacterial - etiology
Skin Diseases, Bacterial - prevention & control
Sunscreening Agents - therapeutic use
xerosis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0190-9622
1097-6787
DOI:10.1016/j.jaad.2016.07.036